Issue 2/2000
Content (10 Articles)
Polyamine profiles in tumor, normal tissue of the homologous breast, blood, and urine of breast cancer sufferers
Jean Levêque, Jean Levêque, Fabrice Foucher, Jean-Yves Bansard, Rene Havouis, Jean-Yves Grall, Jacques-Philippe Moulinoux
T cell suppression as a mechanism for tolerance to MUC1 antigen in MUC1 transgenic mice
Dongshu Chen, Shigeo Koido, Yongqing Li, Sandra Gendler, Jianlin Gong
Cellular responses of mammary carcinomas to aromatase inhibitors: Effects of vorozole
Konstantin Christov, Anne Shilkaitis, Albert Green, Rajendra G. Mehta, Clinton Grubbs, Gary Kelloff, Ronald Lubet
Anti-tumor immunity induced by Interleukin-12 gene therapy in a metastatic model of breast cancer is mediated by natural killer cells
Celia M Divino, Shu-Hsia Chen, Wen Yang, Swan Thung, Steven T Brower, SavioLC Woo
Microsatellite instability markers in breast cancer: A review and study showing MSI was not detected at ‘BAT 25’ and ‘BAT 26’ microsatellite markers in early-onset breast cancer
Shoo Peng Siah, Shoo Peng Siah, Diana M Quinn, Graeme D Bennett, Graeme Casey, Robert LP Flower, Graeme Suthers, Zbigniew Rudzki
RT-PCR amplification of CK19 mRNA in the blood of breast cancer patients: correlation with established prognostic parameters
Harriette J. Kahn, Lu-Ying Yang, John Blondal, Lavina Lickley, Claire Holloway, Wedad Hanna, Steven Narod, David R. McCready, Arun Seth, Alexander Marks, Alexander Marks
β-adrenoceptor signaling and its control of cell replication in MDA-MB-231 human breast cancer cells
Theodore A. Slotkin, Jian Zhang, Ria Dancel, Stephanie J. Garcia, Carrie Willis, Frederic J. Seidler
Analysis of cathepsin D in human breast cancer: Usefulness of the processsed 31 kDa active form of the enzyme as a prognostic indicator in node-negative and node-positive patients
Lee B. Riley, Marianne K. Lange, Richard J. Browne, Peter J. Cochrane, Ik-Joon Choi, Barbara Davis, Stephen Arcona, Jack A. Alhadeff
EORTC 10941: A phase II study of liarozole in postmenopausal patients with ‘Chemotherapy-Resistant’ or ‘Potentially Hormone Sensitive’ metastatic breast cancer
A. Hamilton, J.-A. Roy, L. Beex, M. Piccart, L. Mauriac, R. Coleman, R. Paridaens, G. Hoctin Boes, A. van Vreckem, P. Palmer, J. Klijn